CN104004110B - 一种从瓜子金中提取的瓜子金多糖及其应用 - Google Patents
一种从瓜子金中提取的瓜子金多糖及其应用 Download PDFInfo
- Publication number
- CN104004110B CN104004110B CN201410269634.7A CN201410269634A CN104004110B CN 104004110 B CN104004110 B CN 104004110B CN 201410269634 A CN201410269634 A CN 201410269634A CN 104004110 B CN104004110 B CN 104004110B
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- water
- gold
- hours
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 93
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 93
- 150000004676 glycans Chemical class 0.000 title claims abstract description 80
- 241000146384 Glaux Species 0.000 title 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000010931 gold Substances 0.000 claims abstract description 37
- 229910052737 gold Inorganic materials 0.000 claims abstract description 37
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 36
- 241000353135 Psenopsis anomala Species 0.000 claims abstract description 33
- 239000012141 concentrate Substances 0.000 claims abstract description 24
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 24
- -1 gold polysaccharides Chemical class 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 11
- 230000036737 immune function Effects 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 230000002708 enhancing effect Effects 0.000 claims abstract description 10
- 239000000706 filtrate Substances 0.000 claims abstract description 10
- 239000002244 precipitate Substances 0.000 claims abstract description 10
- 239000011347 resin Substances 0.000 claims abstract description 9
- 229920005989 resin Polymers 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 13
- 235000020238 sunflower seed Nutrition 0.000 claims description 9
- 238000010828 elution Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims 1
- 238000011161 development Methods 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 17
- 206010057249 Phagocytosis Diseases 0.000 description 12
- 230000008782 phagocytosis Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 241000287828 Gallus gallus Species 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 206010061598 Immunodeficiency Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 229960004397 cyclophosphamide Drugs 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 241000208818 Helianthus Species 0.000 description 4
- 235000003222 Helianthus annuus Nutrition 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- 229920001491 Lentinan Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 230000002949 hemolytic effect Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229940115286 lentinan Drugs 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 210000004989 spleen cell Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241000219112 Cucumis Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001638289 Polygala japonica Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410269634.7A CN104004110B (zh) | 2014-06-17 | 2014-06-17 | 一种从瓜子金中提取的瓜子金多糖及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410269634.7A CN104004110B (zh) | 2014-06-17 | 2014-06-17 | 一种从瓜子金中提取的瓜子金多糖及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104004110A CN104004110A (zh) | 2014-08-27 |
CN104004110B true CN104004110B (zh) | 2016-03-02 |
Family
ID=51365036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410269634.7A Expired - Fee Related CN104004110B (zh) | 2014-06-17 | 2014-06-17 | 一种从瓜子金中提取的瓜子金多糖及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104004110B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104926958B (zh) * | 2015-07-13 | 2017-04-19 | 河南中医学院 | 从泽兰中提取泽兰多糖的方法及其应用 |
CN106511492B (zh) * | 2016-12-27 | 2019-12-20 | 南昌大学 | 一种瓜子金提取物的制备及其促海马神经发生的应用 |
CN111620963B (zh) * | 2020-05-13 | 2021-07-20 | 中国科学院上海药物研究所 | 一种多糖及其制备方法和应用 |
-
2014
- 2014-06-17 CN CN201410269634.7A patent/CN104004110B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
瓜子金根的化学成分研究;张东明等;《中草药》;20051212(第12期);1767-1771 * |
Also Published As
Publication number | Publication date |
---|---|
CN104004110A (zh) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101152007B (zh) | 一种保健品组合物及其制备方法 | |
CN108477612B (zh) | 一种包含铁皮石斛纯化提取物的石斛营养粉及制备方法 | |
CN106108000A (zh) | 易被人体吸收的石斛复合超微粉的制备方法 | |
CN103070880B (zh) | 白簕多糖在制备治疗糖尿病药物中的应用 | |
CN101293070A (zh) | 从黄精中提取增强免疫功能作用的黄精低聚糖 | |
CN102552644A (zh) | 大蒜总多糖的抗癌用途、制备方法及组合物 | |
WO2020093510A1 (zh) | 一种灵芝孢子多糖的分离纯化方法 | |
CN104004110B (zh) | 一种从瓜子金中提取的瓜子金多糖及其应用 | |
CN1861637A (zh) | 淮山药多糖制备方法及其用途 | |
CN104013636A (zh) | 瓦草五环三萜皂苷类化合物抗肿瘤的药物用途 | |
CN103211858B (zh) | 一种四君子滴丸制剂 | |
CN102626418B (zh) | 一种鹿衔草多糖在制备增强免疫力药物和保健食品中的应用 | |
WO2020000828A1 (zh) | 一种具有显著降血脂活性的龙须菜多糖及其制备方法与应用 | |
CN105943617A (zh) | 全麻素在制备抗肝炎药物中的应用 | |
CN103784492B (zh) | 具有抗肿瘤作用的铜锤玉带草提取物及其应用 | |
CN103463244A (zh) | 一种从月季花中提取降糖物质的方法及其应用 | |
CN110403967B (zh) | 一种增加人参皂苷Rg3、Rh2含量的人参加工方法及得到的加工人参和应用 | |
CN104892789A (zh) | 一种从白屈菜中提取的白屈菜多糖及其应用 | |
CN106265717A (zh) | 狗肝菜多糖在制备防治糖尿病药物或保健品中的应用 | |
CN101584828B (zh) | 一种清肺中药组合物的制备方法 | |
CN107158084B (zh) | 治疗桥本氏甲状腺炎的药物组合物及其制备方法和用途 | |
CN101322734A (zh) | 具有抗炎免疫作用的轮叶党参总皂苷及其制备方法 | |
CN107412607B (zh) | 一种芦笋胶囊及其制备方法 | |
CN116515009B (zh) | 一种竹荪蛋多糖、提取方法及其在抗胰腺癌中的应用 | |
CN107823448A (zh) | 一种灵芝抗肿瘤复配提取物、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xiaokun Inventor after: Zhang Huafeng Inventor after: Zhang Jie Inventor after: Liu Jiong Inventor after: Liu Fugang Inventor after: Yang Yun Inventor before: Yang Yun Inventor before: Zhang Huafeng Inventor before: Zhang Jie Inventor before: Liu Jiong Inventor before: Liu Fugang |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160302 Termination date: 20160617 |
|
CF01 | Termination of patent right due to non-payment of annual fee |